These authors contributed equally to this study.
Polymorphism at the TNF-alpha gene interacts with Mediterranean diet to influence triglyceride metabolism and inflammation status in metabolic syndrome patients: From the CORDIOPREV clinical trial
Version of Record online: 22 APR 2014
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Molecular Nutrition & Food Research
Volume 58, Issue 7, pages 1519–1527, July 2014
How to Cite
Gomez-Delgado, F., Alcala-Diaz, J. F., Garcia-Rios, A., Delgado-Lista, J., Ortiz-Morales, A., Rangel-Zuñiga, O., Tinahones, F. J., Gonzalez-Guardia, L., Malagon, M. M., Bellido-Muñoz, E., Ordovas, J. M., Perez-Jimenez, F., Lopez-Miranda, J. and Perez-Martinez, P. (2014), Polymorphism at the TNF-alpha gene interacts with Mediterranean diet to influence triglyceride metabolism and inflammation status in metabolic syndrome patients: From the CORDIOPREV clinical trial. Mol. Nutr. Food Res., 58: 1519–1527. doi: 10.1002/mnfr.201300723
Clinical Trial Registration Number: NCT00924937.
- Issue online: 1 JUL 2014
- Version of Record online: 22 APR 2014
- Manuscript Accepted: 25 FEB 2014
- Manuscript Revised: 20 FEB 2014
- Manuscript Received: 2 OCT 2013
- Ministerio de Ciencia e Innovacion. Grant Number: AGL2009-122270 to J L-M, FIS PI10/01041 to P P-M
- Ministerio de Economia y Competitividad. Grant Number: AGL2012/39615 to J L-M
- Consejeria de Salud, Junta de Andalucia. Grant Number: PI0193/09 to J L-M
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Table S1. Inclusion and exclusion criteria for the CORDIOPREV study.
Table S2. Baseline characteristics of the CORDIOPREV study.
Table S3. Summary of dietary measurements and activities performed in the first year of the intervention.
Figure S1. Flow-chart of the CORDIOPREV study and MetS patients.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.